Europe Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Integrated Systems, Semi-Continuous Systems, Controls); Application (End Product Manufacturing, API Manufacturing); End User (Full-Scale Manufacturing Companies, R&D Departments); and, Country
Market Introduction
Continuous manufacturing in the pharmaceutical industry is a result of advancements in technology with respect to the production techniques. In the past years, the traditional method of batch manufacturing was followed in the pharmaceutical industry. However, the development in technology has accelerated mass production with improved quality, and it has addressed the many primary causes such as the recall of drugs and recalls. The pharmaceutical industry has recently begun to acknowledge the continuous manufacturing as an option to improve and sustain manufacturing operations.
With more than 300 pharmaceutical continuous manufacturing companies, the regions such as Missouri, Columbia, Kansas and Manhattan have the most numbers of pharmaceutical continuous manufacturing companies in the whole world.
Get more information on this report :
Market Overview and Dynamics
The Europe pharmaceutical continuous manufacturing market is expected to reach US$ 799.50 Mn in 2027 from US$ 342.41 Mn in 2018. The market is anticipated to grow with a CAGR of 10.0% from 2019-2027. Factors driving the market growth include increasing shortage of medicines. However, high cost involved in drug manufacturing is likely to have a negative impact on market growth.
Key Market Segments
By product, the integrated systems segment accounted for the largest market share in the Europe pharmaceutical continuous manufacturing market in 2018. Based on application, the end product manufacturing segment held the largest market share of the pharmaceutical continuous manufacturing market by 2027. In terms of end user, the full-scale manufacturing companies segment accounted the largest market share of the pharmaceutical continuous manufacturing market by 2027.
Major Sources and Companies Listed
Some of the major primary and secondary sources for pharmaceutical continuous manufacturing market included in the report are, Centers For Disease Control And Prevention (CDC), Defense Research and Development Organization (DRDO), Functional Genomic and Computational Assessment of Threats (Fun GCAT), and among others.
Reasons to buy the report
- To understand the pharmaceutical continuous manufacturing market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for pharmaceutical continuous manufacturing market
- Efficiently plan M&A and partnership deals in pharmaceutical continuous manufacturing market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form pharmaceutical continuous manufacturing market
- Obtain market revenue forecast for market by various segments from 2018-2027 in Europe region.
Europe PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SEGMENTATION
By Product
- Integrated Systems
- Semi-Continuous Systems
- Continuous Granulators
- Continuous Blenders
- Continuous Compressors
- Continuous Coaters
- Continuous Dryers
- Other Semi-Continuous Systems
- Controls
By Application
- End Product Manufacturing
- Solid Dosage Manufacturing
- Liquid Dosage Manufacturing
- API Manufacturing
By End-User
- Full Scale Manufacturing Companies
- Pharmaceutical Companies
- Contract Manufacturing Organizations
- R & D Departments
- Contract Research Organizations
- Research Institutes
By Geography
• Europe
- UK
- Germany
- France
- Italy
- Spain
Company Profiles
- Fette Compacting
- KORSCH AG
- LEISTRITZ AG
- ALEXANDERWERK AG
- Hovione
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Pharmaceutical Continuous Manufacturing Market – By Product
1.3.2 Europe Pharmaceutical Continuous Manufacturing Market – By Application
1.3.3 Europe Pharmaceutical Continuous Manufacturing Market – By End User
1.3.4 Europe Pharmaceutical Continuous Manufacturing Market – By Country
2. Europe Pharmaceutical Continuous Manufacturing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Pharmaceutical Continuous Manufacturing Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe Pharmaceutical Continuous Manufacturing Market - Europe PEST Analysis
4.3 Expert Opinion
5. Europe Pharmaceutical Continuous Manufacturing - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Shortage of Medicines
5.2 Key Restraints
5.2.1 High Cost Involved in Drug Manufacturing
5.3 Key Market Opportunities
5.3.1 Strategic Activities by the Manufacturers
5.4 Future Trend
5.4.1 Increasing Adoption of Continuous Manufacturing in Pharmaceuticals
5.5 Impact Analysis
6. Pharmaceutical Continuous Manufacturing Market – Europe Analysis
6.1 Europe Pharmaceutical Continuous Manufacturing Market Revenue Forecasts and Analysis
7. Pharmaceutical Continuous Manufacturing Market Analysis – By Product
7.1 Overview
7.2 Pharmaceutical Continuous Manufacturing Market Share, by Product, 2019 and 2027 (%)
7.3 Integrated Systems
7.3.1 Overview
7.3.2 Integrated Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4 Semi-Continuous Systems
7.4.1 Overview
7.4.2 Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.3 Continuous Granulators
7.4.3.1 Overview
7.4.3.2 Continuous Granulators: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.4 Continuous Blenders
7.4.4.1 Overview
7.4.4.2 Continuous Blenders: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.5 Continuous Compressors
7.4.5.1 Overview
7.4.5.2 Continuous Compressors: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.6 Continuous Coaters
7.4.6.1 Overview
7.4.6.2 Continuous Coaters: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.7 Continuous Dryers
7.4.7.1 Overview
7.4.7.2 Continuous Dryers: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.8 Other Semi-Continuous Systems
7.4.8.1 Overview
7.4.8.2 Other Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.5 Controls
7.5.1 Overview
7.5.2 Controls: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
8. Pharmaceutical Continuous Manufacturing Market– By Application
8.1 Overview
8.2 Pharmaceutical Continuous Manufacturing Market Share, by Application, 2019 and 2027 (%)
8.3 End Product Manufacturing
8.3.1 Overview
8.3.2 End Product Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
8.3.3 Solid Dosage Manufacturing
8.3.3.1 Overview
8.3.3.2 Solid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
8.3.4 Liquid Dosage Manufacturing
8.3.4.1 Overview
8.3.4.2 Liquid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
8.4 API Manufacturing
8.4.1 Overview
8.4.2 API Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9. Pharmaceutical Continuous Manufacturing Market – By End User
9.1 Overview
9.2 Pharmaceutical Continuous Manufacturing Market Share, by End User, 2019 and 2027 (%)
9.3 Full-Scale Manufacturing Companies
9.3.1 Overview
9.3.2 Full-Scale Manufacturing Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.3.3 Pharmaceutical Companies
9.3.3.1 Overview
9.3.3.2 Pharmaceutical Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.3.4 Contract Manufacturing Organizations
9.3.4.1 Overview
9.3.4.2 Contract Manufacturing Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.4 R&D Departments
9.4.1 Overview
9.4.2 R&D Departments: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.4.3 Contract Research Organizations
9.4.3.1 Overview
9.4.3.2 Contract Research Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.4.4 Research Institutes
9.4.4.1 Overview
9.4.4.2 Research Institutes: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
10. Pharmaceutical Continuous Manufacturing Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 Europe Pharmaceutical Continuous Manufacturing Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 Europe: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 Europe: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.3.1 Europe: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.4 Europe: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.4.1 Europe: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.5 Europe: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.5.1 Europe: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.5.2 Europe: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.1.6 Europe: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
10.1.7 Germany: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Germany: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Germany: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.7.2.1 Germany: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.7.3 Germany: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.7.3.1 Germany: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.7.4 Germany: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.7.4.1 Germany: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.7.4.2 Germany: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.1.8 UK: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 UK: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 UK: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.8.2.1 UK: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.8.3 UK: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.8.3.1 UK: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.8.4 UK: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.8.4.1 UK: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.8.4.2 UK: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.1.9 France: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 France: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 France: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.9.2.1 France: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.9.3 France: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.9.3.1 France: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.9.4 France: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.9.4.1 France: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.9.4.2 France: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.1.10 Spain: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.1 Spain: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.2 Spain: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.10.2.1 Spain: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.10.3 Spain: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.10.3.1 Spain: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.10.4 Spain: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.10.4.1 Spain: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.10.4.2 Spain: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.1.11 Italy: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Italy: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Italy: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.11.2.1 Italy: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.11.3 Italy: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.11.3.1 Italy: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.11.4 Italy: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.11.4.1 Italy: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.11.4.2 Italy: R&D Departments Market, by Type, 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Pharmaceutical Continuous Manufacturing Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 KORSCH AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 LEISTRITZ AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 ALEXANDERWERK AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Hovione
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Fette Compacting
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 2. Europe: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 3. Europe: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 4. Europe: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 5. Europe: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 6. Europe: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 7. Europe: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. Germany: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 9. Germany: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 10. Germany: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 11. Germany: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Germany: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Germany: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Germany: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 15. UK: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 16. UK: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 17. UK: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 18. UK: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 19. UK: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 20. UK: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 21. UK: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 22. France: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 23. France: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 24. France: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 25. France: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 26. France: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 27. France: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 28. France: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 29. Spain: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 30. Spain: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 31. Spain: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 32. Spain: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 33. Spain: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 34. Spain: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 35. Spain: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 36. Italy: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 37. Italy: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 38. Italy: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 39. Italy: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 40. Italy: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 41. Italy: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 42. Italy: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 43. Glossary of Terms, Europe Pharmaceutical Continuous Manufacturing Market
LIST OF FIGURES
Figure 1. Pharmaceutical Continuous Manufacturing Market Segmentation
Figure 2. Europe Pharmaceutical Continuous Manufacturing Market Overview
Figure 3. The Integrated Systems Segment Held Largest Share of Product Segment in Pharmaceutical Continuous Manufacturing Market
Figure 4. Germany Is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Europe Pharmaceutical Continuous Manufacturing Market- Leading Country Markets (US$ Mn)
Figure 6. Europe Pharmaceutical Continuous Manufacturing Market - Europe PEST Analysis
Figure 7. Pharmaceutical Continuous Manufacturing Market Impact Analysis of Drivers and Restraints
Figure 8. Europe Pharmaceutical Continuous Manufacturing Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Pharmaceutical Continuous Manufacturing Market Share, by Product, 2019 and 2027 (%)
Figure 10. Integrated Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 11. Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 12. Continuous Granulators: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 13. Continuous Blenders: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 14. Continuous Compressors: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 15. Continuous Coaters: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 16. Continuous Dryers: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 17. Other Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 18. Controls: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 19. Pharmaceutical Continuous Manufacturing Market Share, by Application, 2019 and 2027 (%)
Figure 20. End Product Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 21. Solid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 22. Liquid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 23. API Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 24. Pharmaceutical Continuous Manufacturing Market Share, by End User, 2019 and 2027 (%)
Figure 25. Full-Scale Manufacturing Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 26. Pharmaceutical Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 27. Contract Manufacturing Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 28. R&D Departments: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 29. Contract Research Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 30. Research Institutes: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 31. Europe: Pharmaceutical Continuous Manufacturing Market, by Key Country – Revenue (2019) (USD Million)
Figure 32. Europe Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027 (USD Million)
Figure 33. Europe: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
Figure 34. Germany: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. UK: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. France: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Spain: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Italy: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Impact of COVID-19 Pandemic in Europe Country Markets
- Fette Compacting
- KORSCH AG
- LEISTRITZ AG
- ALEXANDERWERK AG
- Hovione
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pharmaceutical continuous manufacturing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the pharmaceutical continuous manufacturing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.